BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20943486)

  • 1. [Advances in early diagnosis of colorectal cancer based on detection of RNAs in stool.].
    Qi ZT; Deng LL; Huang H; Zhao JH; Zhou GH
    Yi Chuan; 2010 Oct; 32(10):994-1002. PubMed ID: 20943486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
    Dollinger MM; Behl S; Fleig WE
    Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
    Slaby O
    Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of RNA isolated from feces as a promising tool for the early detection of colorectal cancer.
    Bernal G
    Int J Biol Markers; 2012 Jul; 27(2):e82-9. PubMed ID: 22427189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
    Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J
    Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
    Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
    Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stool DNA Integrity Method for Colorectal Cancer Detection.
    Rengucci C; De Maio G; Menghi M; Calistri D
    Methods Mol Biol; 2018; 1765():193-202. PubMed ID: 29589309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RT-qPCR for Fecal Mature MicroRNA Quantification and Validation.
    Ahmed FE; Ahmed NC; Gouda MM; Vos PW; Bonnerup C
    Methods Mol Biol; 2018; 1765():203-215. PubMed ID: 29589310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
    Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults.
    Haug U; Hillebrand T; Bendzko P; Löw M; Rothenbacher D; Stegmaier C; Brenner H
    Clin Chem; 2007 Apr; 53(4):787-90. PubMed ID: 17317884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages.
    Beaulieu JF; Herring E; Kanaoka S; Tremblay É
    Oncotarget; 2016 Mar; 7(12):14684-92. PubMed ID: 26895101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Stool Multitarget mRNA Assay for the Detection of Colorectal Neoplasms.
    Herring E; Kanaoka S; Tremblay E; Beaulieu JF
    Methods Mol Biol; 2018; 1765():217-227. PubMed ID: 29589311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.
    Iannone A; Losurdo G; Pricci M; Girardi B; Massaro A; Principi M; Barone M; Ierardi E; Di Leo A
    J Gastrointest Cancer; 2016 Jun; 47(2):143-51. PubMed ID: 26922358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA as markers for the diagnostic screening of colon cancer.
    Ahmed FE
    Expert Rev Anticancer Ther; 2014 Apr; 14(4):463-85. PubMed ID: 24580550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved fecal DNA test for colorectal cancer screening.
    Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance improvements of stool-based screening tests.
    van Dam L; Kuipers EJ; van Leerdam ME
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):479-92. PubMed ID: 20833351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
    Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital detection of multiple minority mutants in stool DNA for noninvasive colorectal cancer diagnosis.
    Deng L; Qi Z; Zou B; Wu H; Huang H; Kajiyama T; Kambara H; Zhou G
    Anal Chem; 2012 Jul; 84(13):5645-52. PubMed ID: 22715805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal immunochemical test accuracy in familial risk colorectal cancer screening.
    Castro I; Cubiella J; Rivera C; González-Mao C; Vega P; Soto S; Hernandez V; Iglesias F; Teresa Alves M; Bujanda L; Fernández-Seara J
    Int J Cancer; 2014 Jan; 134(2):367-75. PubMed ID: 23818169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinician's Guide to Fecal Occult Blood Testing for Colorectal Cancer.
    Bechtold ML; Ashraf I; Nguyen DL
    South Med J; 2016 Apr; 109(4):248-55. PubMed ID: 27043809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.